Fresenius Medical Care confirms 2019 targets

(Reuters) - German dialysis specialist Fresenius Medical Care <FMEG.DE> reported on Tuesday a 3% rise in its second-quarter revenue, citing healthy growth in its U.S. dialysis business.

The company confirmed its full-year guidance and still expects sales to rise by 3% to 7%, and adjusted net income change to be in the range of -2% to 2%, after second-quarter revenue came in broadly in line with analysts' expectations in a Refinitiv poll.

(Reporting by Bartosz Dabrowski in Gdynia; Editing by Tomasz Janowski)